Get startedLog in
    Picture of Chemomab Therapeutics logo

    CMMB — Chemomab Therapeutics News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareSpeculativeMicro CapSucker Stock
    All News

    Brief: Chemomab Announces Completion of Patient Enrollment in CM-101 Phase 2 Primary Sclerosing Cholangitis Trial

    Picture of Chemomab Therapeutics logoChemomab Therapeutics
    03/01/2024 12:19
    Jan 3 (Reuters) - Chemomab Therapeutics Ltd  CMMB.O :
    * CHEMOMAB ANNOUNCES COMPLETION OF PATIENT ENROLLMENT IN
CM-101
PHASE 2 PRIMARY SCLEROSING CHOLANGITIS TRIAL AND MOVES UP
EXPECTED TOPLINE READOUT TO MIDYEAR 2024
    * CHEMOMAB THERAPEUTICS LTD - EXPECTS TO REPORT TOPLINE DATA
FROM
PSC CLINICAL TRIAL BY MIDYEAR 2024

Source text for Eikon:  ID:nPnpfs63a 
Further company coverage:  CMMB.O 

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on Chemomab Therapeutics

    See all news